Combination therapy for multiple sclerosis in children
The efficiency of combination therapy for multiple sclerosis was evaluated in 40 children aged 10 to 17 years. Two groups matched for major clinical and laboratory parameters were treated every 6 months during 3 years. Both groups received one cascade plasma filtration session using plasma Evaflux 2...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2016-04-01
|
| Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
| Subjects: | |
| Online Access: | https://www.ped-perinatology.ru/jour/article/view/303 |
| _version_ | 1797875325207576576 |
|---|---|
| author | N. V. Skripchenko G. P. Ivanova A. V. Surovtseva E. Yu. Skripchenko K. V. Serednyakov |
| author_facet | N. V. Skripchenko G. P. Ivanova A. V. Surovtseva E. Yu. Skripchenko K. V. Serednyakov |
| author_sort | N. V. Skripchenko |
| collection | DOAJ |
| description | The efficiency of combination therapy for multiple sclerosis was evaluated in 40 children aged 10 to 17 years. Two groups matched for major clinical and laboratory parameters were treated every 6 months during 3 years. Both groups received one cascade plasma filtration session using plasma Evaflux 2A (Japan) and then intravenous immunoglobulins G during 2 days. Unlike the comparison group (n=10), the study group (n=30) had additionally antiviral and immunomodulatory therapy; the volume and duration of which were determined by the presence or absence of Herpesviridae reactivation in cerebrospinal fluid (CSF) and/or blood. The performed therapy was established to have a positive effect in 90% of the patients in both groups, but the study group showed valid more significant results and achieved decreased reactivation of chronic herpesvirus infections (predominantly that with Epstein–Barr virus and herpesvirus 6) in CSF and blood and reductions in EDSS scores in 80% of cases, by an average of 61%, and in the annual rates of exacerbations by 46%. |
| first_indexed | 2024-04-10T01:44:47Z |
| format | Article |
| id | doaj.art-abaf2633dfae41b380a3736a85de6dd0 |
| institution | Directory Open Access Journal |
| issn | 1027-4065 2500-2228 |
| language | Russian |
| last_indexed | 2024-04-10T01:44:47Z |
| publishDate | 2016-04-01 |
| publisher | Ltd. “The National Academy of Pediatric Science and Innovation” |
| record_format | Article |
| series | Rossijskij Vestnik Perinatologii i Pediatrii |
| spelling | doaj.art-abaf2633dfae41b380a3736a85de6dd02023-03-13T09:12:42ZrusLtd. “The National Academy of Pediatric Science and Innovation”Rossijskij Vestnik Perinatologii i Pediatrii1027-40652500-22282016-04-01612616710.21508/1027-4065-2016-61-2-61-67295Combination therapy for multiple sclerosis in childrenN. V. Skripchenko0G. P. Ivanova1A. V. Surovtseva2E. Yu. Skripchenko3K. V. Serednyakov4ФГБУ «Научно-исследовательский институт детских инфекций» Федерального медико-биологического агентства; ГБОУ ВПО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РФГБОУ ВПО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РФ; ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Минздрава РФФГБУ «Научно-исследовательский институт детских инфекций» Федерального медико-биологического агентстваГБОУ ВПО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РФ; Городская клиническая больница № 31ФГБУ «Научно-исследовательский институт детских инфекций» Федерального медико-биологического агентства; ГБОУ ВПО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РФThe efficiency of combination therapy for multiple sclerosis was evaluated in 40 children aged 10 to 17 years. Two groups matched for major clinical and laboratory parameters were treated every 6 months during 3 years. Both groups received one cascade plasma filtration session using plasma Evaflux 2A (Japan) and then intravenous immunoglobulins G during 2 days. Unlike the comparison group (n=10), the study group (n=30) had additionally antiviral and immunomodulatory therapy; the volume and duration of which were determined by the presence or absence of Herpesviridae reactivation in cerebrospinal fluid (CSF) and/or blood. The performed therapy was established to have a positive effect in 90% of the patients in both groups, but the study group showed valid more significant results and achieved decreased reactivation of chronic herpesvirus infections (predominantly that with Epstein–Barr virus and herpesvirus 6) in CSF and blood and reductions in EDSS scores in 80% of cases, by an average of 61%, and in the annual rates of exacerbations by 46%.https://www.ped-perinatology.ru/jour/article/view/303детирассеянный склерозкаскадная плазмофильтрацияпротивовирусная терапия |
| spellingShingle | N. V. Skripchenko G. P. Ivanova A. V. Surovtseva E. Yu. Skripchenko K. V. Serednyakov Combination therapy for multiple sclerosis in children Rossijskij Vestnik Perinatologii i Pediatrii дети рассеянный склероз каскадная плазмофильтрация противовирусная терапия |
| title | Combination therapy for multiple sclerosis in children |
| title_full | Combination therapy for multiple sclerosis in children |
| title_fullStr | Combination therapy for multiple sclerosis in children |
| title_full_unstemmed | Combination therapy for multiple sclerosis in children |
| title_short | Combination therapy for multiple sclerosis in children |
| title_sort | combination therapy for multiple sclerosis in children |
| topic | дети рассеянный склероз каскадная плазмофильтрация противовирусная терапия |
| url | https://www.ped-perinatology.ru/jour/article/view/303 |
| work_keys_str_mv | AT nvskripchenko combinationtherapyformultiplesclerosisinchildren AT gpivanova combinationtherapyformultiplesclerosisinchildren AT avsurovtseva combinationtherapyformultiplesclerosisinchildren AT eyuskripchenko combinationtherapyformultiplesclerosisinchildren AT kvserednyakov combinationtherapyformultiplesclerosisinchildren |